Pilecki Derek Steven purchased $743 of GROW (indirect holdings)

Pilecki Derek Steven purchased 288 indirectly-held shares of U S GLOBAL INVESTORS INC (GROW) at $2.58 on 2026-11-03.

Original reporting
SEC EDGAR · Pilecki Derek Steven
Published Nov 3, 2026, 9:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GROW
Neutral
high confidence
Mentioned
$GROW
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GROWNeutralLow
01

Why it matters

The disclosed purchase is minor and unlikely to move the stock materially.

02

Market read

Minor insider buy with limited trading relevance.

03

What to watch

Potential future insider activity could signal confidence, but no immediate impact.

Relevance 3/10Novelty 3/10Timing: after-hours filing today

Background

Form 4 filings disclose insider transactions; traders monitor for significant buys or sells.

Company-level read

Ticker impact

$GROWNeutralHigh confidence
Context

SEC Form 4 disclosed insider Derek Pilecki purchased 288 shares of GROW for $743, increasing his holdings to 1,129,299 shares.

Expected impact

slight upward pressure as market prices in the insider buy

Evidence & confidence

The transaction is a primary filing, but the amount ($743) is trivial relative to market cap, limiting material impact.

Market effects

None

None

None

Counterpoint

The purchase is too small to affect price; traders may ignore.

Key entities

  • Derek Pilecki

    Reporter of the Form 4 purchase

  • U S GLOBAL INVESTORS INC

    Issuer of the shares purchased

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GROWMed

U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027 *****************

$GROWMed

U.S. Global Investors Reports $3.1 Million in Net Income for Fiscal Year 2026

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Reports $3.1 Million in Net Income for Fiscal Year 2026 ***********************************************************

$GROWLow

U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Strength Remains Unchanged

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973695.htm EXHIBIT 99.1 ex_973695.htm Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Str

$GROWMedAI 8/10

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

U.S. Global Investors (NASDAQ: GROW) said it will restate EPS for the three- and nine-month periods ended March 31, 2026, due to a miscalculation of basic and diluted weighted-average shares that omitted a component in a supporting spreadsheet. The company said net income, revenues, operating income, cash, and other line items are unchanged. For the quarter, EPS was overstated by $0.02; corrected basic/diluted EPS is $0.21. For nine months, overstated by $0.01; corrected EPS is reflected in an a